Missouri Trust & Investment Company’s Biogen BIIB Stock Holding History

Missouri Trust & Investment Company’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.9M	Buy	10,380 +1,890	+22%	+$348K	0.56%	37
2025 Q4	$1.49M	Buy	8,490 +65	+0.8%	+$10.6K	0.44%	52
2025 Q3	$1.18M	Buy	8,425 +615	+8%	+$83.1K	0.35%	60
2025 Q2	$981K	Buy	7,810 +1,485	+23%	+$185K	0.32%	63
2025 Q1	$866K	Buy	6,325 +2,460	+64%	+$352K	0.3%	67
2024 Q4	$591K	Sell	3,865 -777	-17%	-$131K	0.21%	81
2024 Q3	$900K	Buy	4,642 +760	+20%	+$159K	0.31%	65
2024 Q2	$900K	Buy	3,882 +50	+1%	+$10.9K	0.34%	63
2024 Q1	$826K	Buy	3,832 +370	+11%	+$86.7K	0.32%	67
2023 Q4	$896K	Sell	3,462 -210	-6%	-$51.6K	0.36%	62
2023 Q3	$944K	Buy	3,672 +1,225	+50%	+$328K	0.42%	49
2023 Q2	$697K	Buy	2,447 +180	+8%	+$53.6K	0.39%	65
2023 Q1	$630K	Sell	2,267 -390	-15%	-$108K	0.41%	66
2022 Q4	$736K	Sell	2,657 -2	-0.1%	-$565	0.44%	52
2022 Q3	$710K	Sell	2,659 -226	-8%	-$48K	0.46%	48
2022 Q2	$588K	Buy	2,885 +260	+10%	+$53.2K	0.38%	65
2022 Q1	$553K	Buy	2,625 +510	+24%	+$111K	0.32%	67
2021 Q4	$507K	Buy	+2,115	New	+$544K	0.29%	71

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Missouri Trust & Investment Company's BIIB Position: Q1 2026 in Review

Missouri Trust & Investment Company increased its Biogen (BIIB) stake by 22% in Q1 2026, buying an estimated $348K and bringing the position to 10,380 shares worth $1.9M. The position accounts for 0.56% of the portfolio, ranked #37.

Missouri Trust & Investment Company first reported a position in BIIB in Q4 2021 and has held it in 18 quarters since. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

Missouri Trust & Investment Company held 10,380 shares of Biogen worth $1.9M as of Q1 2026.
Missouri Trust & Investment Company bought 1,890 Biogen shares in Q1 2026, an estimated $348K.
Biogen made up 0.56% of Missouri Trust & Investment Company's portfolio in Q1 2026, its #37 holding.
Missouri Trust & Investment Company first reported a position in Biogen in Q4 2021 and has held it in 18 quarters since.
1,008 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Missouri Trust & Investment Company's 13F filing for Q1 2026, filed 14 May 2026.